LRMR icon

Larimar Therapeutics

116 hedge funds and large institutions have $245M invested in Larimar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

19% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 27

42% less capital invested

Capital invested by funds: $421M → $245M (-$176M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.13M
Puts
$400K
Net Calls
Net Calls Change

Top Buyers

1 +$3.39M
2 +$1.88M
3 +$1.54M
4
BlackRock
BlackRock
New York
+$1.13M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$676K
27
$659K
28
$575K
29
$484K
30
$476K
31
$449K
32
$427K
33
$416K
34
$389K
35
$332K
36
$314K
37
$308K
38
$273K
39
$262K
40
$259K
41
$247K
42
$226K
43
$224K
44
$218K
45
$217K
46
$210K
47
$206K
48
$206K
49
$200K
50
$182K